FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064481621> ?p ?o ?g. }

• W2064481621 endingPage "16" @default.
• W2064481621 startingPage "1" @default.
• W2064481621 abstract "There is a general trend worldwide of an increasing incidence of elderly population. Age is the greatest risk factor for cancer; therefore, this demographic shift is a main reason for an increase of cancer incidence. Lung cancer is a typical disease of the elderly patients. Small cell lung cancer (SCLC) accounts for approximately 20% of all lung cancer cases. This review summarises the issues of treatment of SCLC in elderly. The number of randomised phase III trials concerning treatment of SCLC in elderly patients are very limited. Although currently most treatment decisions are based on lower grades of evidence, some conclusions can be drawn from the current studies. Age alone is a very uncertain prognostic criteria for outcome or tolerability of treatment. Much more important is the geriatric assessment of each individual patient. Current treatment standards for limited disease (LD)-SCLC (polychemotherapy plus local thoracic irradiation and additional prophylactic cranial irradiation in case of complete remission) seems to be also feasible for 'fit' elderly (>70 years) LD-SCLC patients with a good performance and full functional capacities. There are preliminary data indicating that a similar outcome in elderly patients can probably be achieved a with reduced number of treatment schedules (e.g. 2 instead of 4 cycles in combination with radiotherapy. Surgical resection is also feasible in selected elderly patients with very early stage SCLC, where this maybe an appropriate approach, although no phase III data are available, which demonstrated the benefit of additional surgery compared to chemotherapy alone in early stage SCLC. In patients with extensive disease-SCLC age alone does not necessarily restrict the use of multiagent regimen, although the risk of haematological toxicity seems to be higher than in the younger patients. When standard treatment is not feasible due to co-morbidity or loss of functional capacity, several alternative combination regimens are available, which appear to be slightly superior to single agent treatment, although randomised data for elderly on that issue are sparse. Carboplatin and etoposide seems currently the most appropriate two-drug combination in elderly patients, but there are a variety of active and low toxic third generation agents like taxanes, gemcitabine and vinorelbine which are active in both, non-small cell lung cancer and SCLC. For the comparison of trials in elderly patients it will be of key importance to include a comprehensive and standardised geriatric assessment in such studies." @default.
• W2064481621 created "2016-06-24" @default.
• W2064481621 creator A5029197290 @default.
• W2064481621 creator A5058609591 @default.
• W2064481621 creator A5078383767 @default.
• W2064481621 creator A5083406305 @default.
• W2064481621 date "2003-04-01" @default.
• W2064481621 modified "2023-10-15" @default.
• W2064481621 title "Treatment of lung cancer in elderly part II: small cell lung cancer" @default.
• W2064481621 cites W1822569953 @default.
• W2064481621 cites W1851872955 @default.
• W2064481621 cites W1895855332 @default.
• W2064481621 cites W1900867937 @default.
• W2064481621 cites W1905406155 @default.
• W2064481621 cites W1910638072 @default.
• W2064481621 cites W1912196342 @default.
• W2064481621 cites W1964560183 @default.
• W2064481621 cites W1968483728 @default.
• W2064481621 cites W1969134886 @default.
• W2064481621 cites W1977369125 @default.
• W2064481621 cites W1990319149 @default.
• W2064481621 cites W1990375698 @default.
• W2064481621 cites W1991272247 @default.
• W2064481621 cites W1991469663 @default.
• W2064481621 cites W1994904679 @default.
• W2064481621 cites W1999960570 @default.
• W2064481621 cites W2012814231 @default.
• W2064481621 cites W2013123615 @default.
• W2064481621 cites W2013436842 @default.
• W2064481621 cites W2017967967 @default.
• W2064481621 cites W2026074901 @default.
• W2064481621 cites W2039123736 @default.
• W2064481621 cites W2044746763 @default.
• W2064481621 cites W2059009735 @default.
• W2064481621 cites W2059047654 @default.
• W2064481621 cites W2062668422 @default.
• W2064481621 cites W2064003771 @default.
• W2064481621 cites W2067785379 @default.
• W2064481621 cites W2067965045 @default.
• W2064481621 cites W2082851735 @default.
• W2064481621 cites W2084568415 @default.
• W2064481621 cites W2087873972 @default.
• W2064481621 cites W2094266327 @default.
• W2064481621 cites W2100255788 @default.
• W2064481621 cites W2102235447 @default.
• W2064481621 cites W2110182487 @default.
• W2064481621 cites W2123586708 @default.
• W2064481621 cites W2124353451 @default.
• W2064481621 cites W2134719937 @default.
• W2064481621 cites W2135216934 @default.
• W2064481621 cites W2145188374 @default.
• W2064481621 cites W2149669106 @default.
• W2064481621 cites W2154060376 @default.
• W2064481621 cites W2156836360 @default.
• W2064481621 cites W2171277987 @default.
• W2064481621 cites W2180933151 @default.
• W2064481621 cites W2229509524 @default.
• W2064481621 cites W2233083084 @default.
• W2064481621 cites W2279873332 @default.
• W2064481621 cites W2289067730 @default.
• W2064481621 cites W2315762880 @default.
• W2064481621 cites W2339444986 @default.
• W2064481621 cites W2341745217 @default.
• W2064481621 cites W2421387584 @default.
• W2064481621 cites W2462540693 @default.
• W2064481621 cites W2668112190 @default.
• W2064481621 cites W4230729320 @default.
• W2064481621 cites W4242813288 @default.
• W2064481621 cites W4249037581 @default.
• W2064481621 cites W4367435821 @default.
• W2064481621 cites W71298900 @default.
• W2064481621 doi "https://doi.org/10.1016/s0169-5002(02)00524-x" @default.
• W2064481621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12660002" @default.
• W2064481621 hasPublicationYear "2003" @default.
• W2064481621 type Work @default.
• W2064481621 sameAs 2064481621 @default.
• W2064481621 citedByCount "38" @default.
• W2064481621 countsByYear W20644816212012 @default.
• W2064481621 countsByYear W20644816212013 @default.
• W2064481621 countsByYear W20644816212014 @default.
• W2064481621 countsByYear W20644816212016 @default.
• W2064481621 countsByYear W20644816212017 @default.
• W2064481621 countsByYear W20644816212020 @default.
• W2064481621 countsByYear W20644816212022 @default.
• W2064481621 crossrefType "journal-article" @default.
• W2064481621 hasAuthorship W2064481621A5029197290 @default.
• W2064481621 hasAuthorship W2064481621A5058609591 @default.
• W2064481621 hasAuthorship W2064481621A5078383767 @default.
• W2064481621 hasAuthorship W2064481621A5083406305 @default.
• W2064481621 hasConcept C120665830 @default.
• W2064481621 hasConcept C121332964 @default.
• W2064481621 hasConcept C121608353 @default.
• W2064481621 hasConcept C126322002 @default.
• W2064481621 hasConcept C141071460 @default.
• W2064481621 hasConcept C143998085 @default.
• W2064481621 hasConcept C146357865 @default.
• W2064481621 hasConcept C151730666 @default.
• W2064481621 hasConcept C197934379 @default.

• next